Medication info
Gladiam 4 mg Tablets (Glymepride)

Gladiam 4 mg Tablets (Glymepride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›4mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Pale blue rectangular tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200500561 · Notified 2005.06.28 · Insurance code 642100080

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medication is administered orally once daily. Take this medication before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medication. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional effect at doses above 4 mg, but some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic agent. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this medication may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering agent to this medication There is no exact dose equivalence between this medication and other oral blood glucose-lowering agents. When switching from another oral blood glucose-lowering agent to this medication, it is recommended to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previously administered medication should be taken into account. 4) Dose adjustment during treatment While taking this medication, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite initial successful management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medication and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medication once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medication, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. With combination therapy of this medication and metformin, the desired blood glucose level can be achieved by adjusting the dose of each medication. However, efforts should be made to determine the minimum effective dose of each medication for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medication and metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used as an adjunct to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone or in combination with other medications alongside dietary therapy and exercise. For instance, it can be used together with insulin when oral hypoglycemic agents are insufficient for blood sugar control. If blood sugar is not well controlled with sulfonylureas or metformin monotherapy, it can also be combined with metformin. It supports blood sugar control through various methods, aiding in the health management of patients.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medication is administered orally once daily. Take this medication before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medication. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional effect at doses above 4 mg, but some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic agent. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this medication may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering agent to this medication There is no exact dose equivalence between this medication and other oral blood glucose-lowering agents. When switching from another oral blood glucose-lowering agent to this medication, it is recommended to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previously administered medication should be taken into account. 4) Dose adjustment during treatment While taking this medication, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite initial successful management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medication and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medication once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medication, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. With combination therapy of this medication and metformin, the desired blood glucose level can be achieved by adjusting the dose of each medication. However, efforts should be made to determine the minimum effective dose of each medication for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medication and metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a coma. Additionally, patients allergic to this medication or sulfonylurea medications should not take it. Switching to insulin therapy is recommended for patients with severe liver or kidney dysfunction. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Insulin therapy may be needed for patients with severe infections or those undergoing surgery. Patients with gastrointestinal disorders may be at risk of hypoglycemia due to poor food absorption, so caution is advised. During the first week of taking this medication, there is a high risk of hypoglycemia, so careful monitoring of blood sugar levels is required. This is particularly important for elderly patients, those with poor nutritional status or irregular eating habits, and those who frequently consume alcohol. Patients with reduced kidney or liver function may also be sensitive to hypoglycemia; therefore, dosage adjustments may be necessary. Patients with existing thyroid, pituitary, or adrenal dysfunction should be cautious of the risk of hypoglycemia. Furthermore, when taken with other medications, interactions may affect blood sugar control, so it is important to inform the pharmacist or physician. Because this medication lowers blood sugar, symptoms of hypoglycemia may occur. Symptoms of hypoglycemia include headache, severe hunger, nausea, fatigue, anxiety, confusion, tremors, dizziness, drowsiness, and decreased consciousness. In severe cases, it may lead to seizures or coma, so immediate intake of sugar or seeking medical assistance is necessary when symptoms appear. Additionally, during the initial stage of taking this medication, temporary blurred vision may occur, and gastrointestinal issues, liver function abnormalities, or blood abnormalities may arise. In case of allergic reactions, stop taking the medication immediately and consult medical personnel. While taking this medication, regular meals, exercise, and weight management are necessary for optimal blood sugar control. It is advisable to always carry food containing sugar to prevent hypoglycemia, and artificial sweeteners do not help in managing hypoglycemia. Also, during the treatment, regular checks of blood sugar and urine should be conducted to monitor effectiveness and side effects. If other health issues arise or lifestyle changes occur during medication, it may be necessary to consult a physician for dosage adjustments. Caution is also required when driving or operating machinery during treatment. This medication is metabolized in the liver, so interactions may occur when taken with other drugs. In particular, combinations with certain antibiotics, antifungals, anticoagulants, steroids, and beta-blockers may affect blood sugar control, so it is essential to inform medical personnel about all medications currently being taken. Alcohol consumption can also cause fluctuations in blood sugar, so caution is advised. Women who are pregnant or nursing are advised not to take this medication, and it is best to switch to insulin therapy if necessary. In cases of overdose, severe hypoglycemia can occur, necessitating immediate treatment at a medical institution, and in emergency situations, a glucose injection may be required. The safety of this medication in children has not been established, and elderly patients may require dosage adjustments due to decreased kidney function.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, skin and mucosal syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste abnormalities, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, indigestion, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale blue rectangular tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.